Back
Esperion Therapeutics Stock Predictions
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
14
ESPR
Esperion Therapeutics
Last Price:
$1.70
Seasonality Move:
3.95%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the Founder That's Revolutionizing Smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Esperion Therapeutics Stock Forecast
-
Is Esperion Therapeutics Stock Undervalued?The current Esperion Therapeutics [ESPR] share price is $1.69. The Score for ESPR is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
-
ESPR is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Esperion Therapeutics Stock Go Up Next Year?
Data Unavailable
Esperion Therapeutics Stock Rating
Data Unavailable
Esperion Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
esperion.com
52-Week Data
52-Week High:
3.94
52-Week Low:
1.47
Prediction Charts
Market Cap:
334.4M
Price in USD:
1.69
Volume:
5M
Beta:
1.22
Technical Analysis
SMA50:
1.86
SMA100:
2.15
SMA200:
2.13
52-Wk Change:
-19.91%
Stock Predictions
-
Is Esperion Therapeutics stock public?Yes, Esperion Therapeutics is a publicly traded company.
-
What is the Esperion Therapeutics stock quote today?The Esperion Therapeutics stock price is 1.69 USD today.
-
How to buy Esperion Therapeutics stock online?You can buy Esperion Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-3 | 1.75 | 1.58 | 1.75 | 1.57 |
| Mar-4 | 1.65 | 1.78 | 1.86 | 1.60 |
| Mar-5 | 1.78 | 1.65 | 1.80 | 1.64 |
| Mar-6 | 1.61 | 1.59 | 1.67 | 1.58 |
| Mar-7 | 1.57 | 1.69 | 1.71 | 1.56 |
| Mar-11 | 1.59 | 1.55 | 1.61 | 1.50 |
| Mar-12 | 1.57 | 1.52 | 1.58 | 1.50 |
| Mar-13 | 1.52 | 1.50 | 1.61 | 1.47 |
| Mar-14 | 1.51 | 1.50 | 1.58 | 1.49 |
| Mar-17 | 1.50 | 1.54 | 1.54 | 1.48 |
| Mar-18 | 1.54 | 1.58 | 1.59 | 1.47 |
| Mar-19 | 1.57 | 1.67 | 1.68 | 1.56 |
| Mar-20 | 1.62 | 1.62 | 1.69 | 1.59 |
| Mar-21 | 1.61 | 1.69 | 1.72 | 1.60 |
Esperion Therapeutics Earnings
Data Unavailable
Esperion Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.19 per share.
* Esperion Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.